APLS

Apellis Pharmaceuticals, Inc.

Contracts

Total Value

Stock Metrics

12.9%

Short % Float

3.1d to cover · Moderate squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

10.6% of float

83.2M sh

Public Float

25/100

Dilution Score

Low

15 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

25/100

LOW

Inst: 1.1% · Top: Blackrock Inc.

Biotech Analytics

Complement Inhibitors

32.04

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk25

Clinical Trials50

Short Interest50